The Journal of Immunology, Vol 146, Issue 11 3809-3814, Copyright © 1991 by American Association of Immunologists

ARTICLES

Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors

N Sidell, T Taga, T Hirano, T Kishimoto and A Saxon
Department of Pathology, UCLA School of Medicine 90024.

In this report we demonstrate that retinoic acid (RA) down-regulated the number of IL-6R on human leukocyte cell lines, including the myeloma cell line AF10, and two B cell hybridomas that correspond to cells at earlier stages of B cell development. Using AF10 cells, whose growth was determined to be mediated by the autocrine action of IL-6, we found that RA reduction of IL-6R was concentration-dependent over a range of 10(-11) to 10(-5) M and corresponded to the ability of the retinoid to inhibit cell proliferation. The down-regulation of IL-6R number by RA was accompanied by reduced IL-6R mRNA expression. RA did not affect endogeneous IL-6 synthesis or secretion from AF10 cells. However, addition of exogenous rIL-6 could overcome RA-induced growth inhibition. Menthol, a structurally unrelated compound to RA, also suppressed IL-6R expression and, correspondingly, inhibited cell growth. Taken together, our results suggest that the antiproliferative action of RA on AF10 cells is caused by reduction of IL-6R expression and subsequent inhibition of IL-6-mediated autocrine growth. These findings suggest the possibility that down-regulation of IL-6R is a means by which RA can modulate immune function.

This article has been cited by other articles:

				C. Tabata, R. Tabata, Y. Kadokawa, S. Hisamori, M. Takahashi, M. Mishima, T. Nakano, and H. Kubo Thalidomide Prevents Bleomycin-Induced Pulmonary Fibrosis in Mice J. Immunol., July 1, 2007; 179(1): 708 - 714. [Abstract] [Full Text] [PDF]

				C. Tabata, Y. Kadokawa, R. Tabata, M. Takahashi, K. Okoshi, Y. Sakai, M. Mishima, and H. Kubo All-trans-Retinoic Acid Prevents Radiation- or Bleomycin-induced Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., December 15, 2006; 174(12): 1352 - 1360. [Abstract] [Full Text] [PDF]

				C. Tabata, H. Kubo, R. Tabata, M. Wada, K. Sakuma, M. Ichikawa, S. Fujita, T. Mio, and M. Mishima All-trans retinoic acid modulates radiation-induced proliferation of lung fibroblasts via IL-6/IL-6R system Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L597 - L606. [Abstract] [Full Text] [PDF]

				D. M. Aboulafia, D. Norris, D. Henry, R. J. Grossman, J. Thommes, D. Bundow, R. C. Yocum, and V. Stevens 9-cis-Retinoic Acid Capsules in the Treatment of AIDS-Related Kaposi Sarcoma: Results of a Phase 2 Multicenter Clinical Trial Arch Dermatol, February 1, 2003; 139(2): 178 - 186. [Abstract] [Full Text] [PDF]

				J. Sammons, N. Ahmed, M.A. Khokher, and H.T. Hassan Mechanisms Mediating the Inhibitory Effect of All-Trans Retinoic Acid on Primitive Hematopoietic Stem Cells in Human Long-Term Bone Marrow Culture Stem Cells, May 1, 2000; 18(3): 214 - 219. [Abstract] [Full Text]

				K. Takeda, T. Ichiki, Y. Funakoshi, K. Ito, and A. Takeshita Downregulation of Angiotensin II Type 1 Receptor by All-trans Retinoic Acid in Vascular Smooth Muscle Cells Hypertension, January 1, 2000; 35(1): 297 - 302. [Abstract] [Full Text] [PDF]

				Y.-H. Chen, D. Lavelle, J. DeSimone, S. Uddin, L. C. Platanias, and M. Hankewych Growth Inhibition of a Human Myeloma Cell Line by All-trans Retinoic Acid Is Not Mediated Through Downregulation of Interleukin-6 Receptors but Through Upregulation of p21WAF1 Blood, July 1, 1999; 94(1): 251 - 259. [Abstract] [Full Text] [PDF]

				S. E. Krown Clinical Overview: Issues in Kaposi's Sarcoma Therapeutics J Natl Cancer Inst Monographs, April 1, 1998; 1998(23): 59 - 63. [Abstract] [Full Text]